Barrier Therapeutics, Inc. (NASDAQ: BTRX), a pharmaceutical company that develops and markets dermatology products, today announced that it has received a $12 million senior secured credit facility from Merrill Lynch Capital, a division of Merrill Lynch Business Financial Services Inc., to finance ongoing working capital requirements of its commercial operations.
From: www.sys-con.com
Barrier Therapeutics Establishes $12 Million Credit Facility
Posted by Ruslan Abuzant at 11:02 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment